Che Wang Used Cars

Ruipu Biology, as a leading enterprise in China's animal health products industry and the only listed company on China's A-share market focusing on veterinary drugs, aims at the forefront of international biotechnology and veterinary medicine development, addresses the national needs for sustainable agricultural development, and upholds the corporate philosophy of "Forward-looking, Innovative, Integrity, Sharing", contributing to the industry's technological progress, the healthy development of animal husbandry, and the safety of animal-derived food with high-quality, high-efficiency products.
Ruipu Biology was established in 1998. Over more than ten years of entrepreneurship, it has continuously innovated and forged ahead, growing from a single enterprise into a large-scale animal health industry cluster. It owns six GMP production bases: Ruipu (Tianjin) Biological Pharmaceutical Co., Ltd., Ruipu (Baoding) Biological Pharmaceutical Co., Ltd., Tianjin Ruipu Biological Technology Co., Ltd. High-tech Branch, Hubei Longxiang Pharmaceutical Co., Ltd. (equity participation), Hunan Zhong'an Biological Pharmaceutical Co., Ltd. (equity participation), and Inner Mongolia Ruipu Dadi Animal Pharmaceutical Co., Ltd. (equity participation). It has 30 large-scale production lines including APIs, powders/premixes, oral liquids, disinfectants, injections, granules, tablets, inactivated vaccines, and live vaccines. With its huge production capacity, it has become one of China's largest and most comprehensive animal health product production bases, integrating biological vaccines, pharmaceutical raw materials, pharmaceutical preparations, and feed additives.